Original
Análisis de la efectividad, seguridad y optimización de tocilizumab en una cohorte de pacientes con artritis reumatoide en práctica clínica
Analysis of effectiveness, safety and optimization of tocilizumab in a cohort of patients with rheumatoid arthritis in clinical practice
Natalia Mena-Vázquez, Sara Manrique-Arija, Marta Rojas-Giménez, Inmaculada Ureña-Garnica, Francisco G. Jiménez-Núñez, Antonio Fernández-Nebro
Autor para correspondencia
Unidad de Gestión Clínica de Reumatología, Instituto de investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España
Leído
12717
Vecesse ha leído el artículo
3750
Total PDF
8967
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 8 | 13 |
| 2025 5 | 201 | 74 | 275 |
| 2025 4 | 187 | 48 | 235 |
| 2025 3 | 158 | 55 | 213 |
| 2025 2 | 152 | 52 | 204 |
| 2025 1 | 122 | 53 | 175 |
| 2024 12 | 109 | 48 | 157 |
| 2024 11 | 169 | 74 | 243 |
| 2024 10 | 86 | 40 | 126 |
| 2024 9 | 94 | 23 | 117 |
| 2024 8 | 102 | 39 | 141 |
| 2024 7 | 174 | 43 | 217 |
| 2024 6 | 125 | 37 | 162 |
| 2024 5 | 103 | 33 | 136 |
| 2024 4 | 106 | 63 | 169 |
| 2024 3 | 116 | 43 | 159 |
| 2024 2 | 52 | 31 | 83 |
| 2024 1 | 57 | 22 | 79 |
| 2023 12 | 86 | 24 | 110 |
| 2023 11 | 114 | 52 | 166 |
| 2023 10 | 131 | 38 | 169 |
| 2023 9 | 140 | 55 | 195 |
| 2023 8 | 134 | 22 | 156 |
| 2023 7 | 91 | 25 | 116 |
| 2023 6 | 79 | 36 | 115 |
| 2023 5 | 92 | 47 | 139 |
| 2023 4 | 75 | 33 | 108 |
| 2023 3 | 128 | 25 | 153 |
| 2023 2 | 95 | 39 | 134 |
| 2022 1 | 77 | 24 | 101 |
| 2022 12 | 145 | 54 | 199 |
| 2022 11 | 103 | 46 | 149 |
| 2022 10 | 138 | 62 | 200 |
| 2022 9 | 88 | 47 | 135 |
| 2022 8 | 80 | 47 | 127 |
| 2022 7 | 98 | 63 | 161 |
| 2022 6 | 119 | 55 | 174 |
| 2022 5 | 181 | 77 | 258 |
| 2022 4 | 168 | 78 | 246 |
| 2022 3 | 180 | 62 | 242 |
| 2022 2 | 213 | 64 | 277 |
| 2021 1 | 205 | 76 | 281 |
| 2021 12 | 132 | 49 | 181 |
| 2021 11 | 131 | 45 | 176 |
| 2021 10 | 128 | 83 | 211 |
| 2021 9 | 131 | 58 | 189 |
| 2021 8 | 114 | 38 | 152 |
| 2021 7 | 136 | 34 | 170 |
| 2021 6 | 158 | 57 | 215 |
| 2021 5 | 132 | 78 | 210 |
| 2021 4 | 481 | 103 | 584 |
| 2021 3 | 290 | 47 | 337 |
| 2021 2 | 116 | 20 | 136 |
| 2020 1 | 128 | 22 | 150 |
| 2020 12 | 73 | 36 | 109 |
| 2020 11 | 80 | 30 | 110 |
| 2020 10 | 90 | 32 | 122 |
| 2020 9 | 131 | 42 | 173 |
| 2020 8 | 115 | 61 | 176 |
| 2020 7 | 140 | 44 | 184 |
| 2020 6 | 115 | 42 | 157 |
| 2020 5 | 116 | 52 | 168 |
| 2020 4 | 94 | 35 | 129 |
| 2020 3 | 86 | 40 | 126 |
| 2020 2 | 71 | 37 | 108 |
| 2020 1 | 82 | 32 | 114 |
| 2019 12 | 59 | 35 | 94 |
| 2019 11 | 64 | 47 | 111 |
| 2019 10 | 96 | 39 | 135 |
| 2019 9 | 81 | 46 | 127 |
| 2019 8 | 78 | 54 | 132 |
| 2019 7 | 87 | 44 | 131 |
| 2019 6 | 1 | 2 | 3 |
| 2019 4 | 2 | 6 | 8 |
| 2019 3 | 9 | 4 | 13 |
| 2019 2 | 8 | 4 | 12 |
| 2019 1 | 38 | 12 | 50 |
| 2018 12 | 77 | 51 | 128 |
| 2018 11 | 8 | 10 | 18 |
| 2018 10 | 9 | 17 | 26 |
| 2018 9 | 2 | 12 | 14 |
| 2018 8 | 0 | 8 | 8 |
| 2018 7 | 0 | 2 | 2 |
| 2018 4 | 0 | 25 | 25 |
| 2018 3 | 0 | 24 | 24 |
| 2018 2 | 0 | 12 | 12 |
| 2018 1 | 0 | 16 | 16 |
| 2017 12 | 0 | 21 | 21 |
| 2017 11 | 0 | 30 | 30 |
| 2017 10 | 0 | 31 | 31 |
| 2017 9 | 0 | 30 | 30 |
| 2017 8 | 0 | 38 | 38 |
| 2017 7 | 0 | 76 | 76 |
Mostrar todo
